SMC021 Placebo

DRUG2 trials

Sponsors

Nordic Bioscience A/S

Conditions

OsteoarthritisOsteoporosis

Phase 3

Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis

CompletedNCT00486434

Nordic Bioscience A/SOsteoarthritis

Start: 2007-05-31End: 2010-09-30Updated: 2019-04-26

A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D

CompletedNCT00525798

Nordic Bioscience A/SOsteoporosis

Start: 2007-03-31End: 2011-11-30Updated: 2012-10-29

Related Papers

Therapeutic subtypes of knee osteoarthritis: differential treatment effects among predicted endotypes in past clinical trials

Arthritis Research & Therapy2026-05-07

Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis.

2019-09-0340 citations

Identification of pain categories associated with change in pain in patients receiving placebo: data from two phase 3 randomized clinical trials in symptomatic knee osteoarthritis.

2018-01-177 citations

Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.

2015-01-0994 citations

OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA.

2015-01-0846 citations